Cargando…
Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors
Cancer is one of the three leading causes of death worldwide. Even after successful therapy and achieving remission, the risk of relapse often remains. In this context, dormant residual cancer cells in secondary organs such as the bone marrow constitute the cellular reservoir from which late tumor r...
Autores principales: | Heidrich, Isabel, Deitert, Benjamin, Werner, Stefan, Pantel, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014694/ https://www.ncbi.nlm.nih.gov/pubmed/36607507 http://dx.doi.org/10.1007/s10555-022-10075-x |
Ejemplares similares
-
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer
por: Heidrich, Isabel, et al.
Publicado: (2021) -
Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts
por: Heidrich, Isabel, et al.
Publicado: (2022) -
Advances in liquid biopsy approaches for early detection and monitoring of cancer
por: Babayan, Anna, et al.
Publicado: (2018) -
Tumor dormancy and disease recurrence
por: Kirkland, James L.
Publicado: (2023) -
Current and Future Clinical Applications of ctDNA in Immuno-Oncology
por: Stadler, Julia-Christina, et al.
Publicado: (2022)